Meta-Analysis of the Effect of Placebo on the Outcome of Medically Treated Reflux Esophagitis

References

• Blum A L. Is placebo the ideal anti-ulcer drug?. Peptic ulcer disease, G Bianchi Porro, K D Bardhan. Cortina International, Verona 1982; 57–61
   Google Scholar
• Bell N JV, Hunt R H. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992; 33: 118–24
   PubMed Web of Science ®Google Scholar
• Feldman M, Burton M E. Histamine 2-receptor antagonists. Standard therapy for acid-peptic diseases. N Engl J Med 1990; 323: 1749–55
   PubMed Web of Science ®Google Scholar
• Bianchi Porro G, Parente F. Factors influencing peptic ulcer healing. Mechanism of peptic ulcer healing, F Halter, A Garner, G Tytgat. Kluver Academic Publisher, Dordrecht 1991; 249–57
   Google Scholar
• Savary M, Miller G. The esophagus. Handbook and atlas of endoscopy. Gassman, Solothurn 1978
   Google Scholar
• Sacks H S, Berrier J, Reitman D, Ancona-Berk V A, Chalmers T C. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316: 450–5
   PubMed Web of Science ®Google Scholar
• Wesdorp E, Bartelsman J, Pape K, et al. Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology 1978; 74: 821–4
   PubMed Web of Science ®Google Scholar
• Lepsien G, Sonnenberg A, Berges W, et al. Die Behandlung der Roefluxoesphagitis mit Cimetidin. Dtsch Med Wochenschr 1979; 12: 901–6
   Google Scholar
• Brown P. Cimetidine in the treatment of reflux esophagitis. Med J Aust 1979; 2: 96–7
   PubMed Web of Science ®Google Scholar
• Fiasse R, Hanin C, Lepot A, et al. Controlled trial of cimetidine in reflux esophagitis. Dig Dis Sci 1980; 25: 750–5
   PubMed Web of Science ®Google Scholar
• Festen H PM, Driessen W MM, Lamers C BH, et al. Cimetidine in the treatment of severe reflux oesophagitis. Results of an 8-week double-blind study and a subsequent long-term maintenance. Meth J Med 1980; 23: 237–40
   Google Scholar
• Breen K J, Desmond P V, Whelan G. Treatment of reflux esophagitis. A randomized controlled evaluation of cimetidine. Med J Aust 1983; 2: 555–8
   PubMed Web of Science ®Google Scholar
• Farup P G, Weberg R, Berstad A, Wetterhus S, Dahlberg O, Dybdahl J, et al. Low-dose antacid versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study. Scand J Gastroenterol 1990; 25: 315–20
   PubMed Web of Science ®Google Scholar
• Palmer R H, Frank W O, Rochold F W, Wetherington J, Young M D. Cimetidine 800 mg twice daily for healing erosions and ulcers in gastroesophageal reflux disease. J Clin Gastroenterol 1990; 12(Suppl 2)S29–34
   PubMedGoogle Scholar
• Goy J A, Maynard J H, McNaughton W M, O'Shea A. Ranitidine and placebo in the treatment of reflux oesophagitis. A double blind randomized trial. Med J Aust 1983; 2: 558–61
   PubMed Web of Science ®Google Scholar
• Wesdorp I CE, Dekker W, Klinkenberg-Knol E C. Treatment of reflux oesophagitis with ranitidine. Gut 1983; 24: 921–4
   PubMed Web of Science ®Google Scholar
• Sherbaniuk R, Wensel R, Bailey R, et al. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease. J Clin Gastroenterol 1984; 6: 9–15
   PubMed Web of Science ®Google Scholar
• Lehtola J, Niemela S, Martikainen J, Krekela I. Ranitidine 150 mg three times a day in the treatment of reflux esophagitis. A placebo-controlled, double blind, study. Scand J Gastroenterol 1986; 21: 175–80
   PubMed Web of Science ®Google Scholar
• Johansson K E, Boeryd B, Johansson K, Tibbling L. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease [review]. Scand J Gastroenterol 1986; 21: 769–78
   PubMed Web of Science ®Google Scholar
• Sontag S, Robinson M, McAllum R W, et al. Ranitidine therapy for gastroesophageal reflux disease: results of a large double-blind trial. Arch Intern Med 1987; 147: 1485–91
   PubMedGoogle Scholar
• Weiss W. Klinische Erfahrungen mit Ulcogant bei der Reflux-oesophagitis. Swiss Med 1983; 5: 21–4
   Google Scholar
• Carling L, Cronstedt J, Engquist A, Kagevi I, Nystrom B, Svedberg L-E, et al. Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study. Scand J Gastroenterol 1988; 23: 1117–24
   PubMed Web of Science ®Google Scholar
• McCallum R W, Find S M, et al. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. Am J Gastroenterol 1984; 79: 165–72
   PubMed Web of Science ®Google Scholar
• Niemelä S, Jääskeläinen T, Lehtola J, Martikainen J, Krekela I, Sarna S, et al. Pirenzepine in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study. Scand J Gastroenterol 1986; 21: 1193–9
   PubMed Web of Science ®Google Scholar
• Baldi F, Bianchi Porro G, Dobrilla G, et al. Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol 1988; 10: 614–8
   PubMed Web of Science ®Google Scholar
• Lepoutre L, Van Der Spek P, Vanderlinden I, Bollen J, Laukens P. Healing of grade II and III oesophagitis through motility stimulation with cisapride. Digestion 1990; 45: 109–14
   PubMed Web of Science ®Google Scholar
• Hetzel D J, Dent J, Reed W D, et al. healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–12
   PubMed Web of Science ®Google Scholar
• Quick R FP, Cooper M J, Gleeson M, et al. A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis. Aliment Pharmacol Ther 1990; 4: 201–11
   PubMed Web of Science ®Google Scholar
• Graham D Y, Patterson D J. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci 1983; 83: 559–65
   Google Scholar
• Powell-Jackson P, Barkley H, Northfield T C. Effect of cimetidine in symptomatic gastrooesophageal reflux. Lancet 1978; 2: 1068–9
   PubMed Web of Science ®Google Scholar
• Behar J, Brand D L, Brown F C, et al. Cimetidine in the treatment of symptomatic gastroesophageal reflux. A double blind controlled trial. Gastroenterology 1978; 74: 441–8
   PubMed Web of Science ®Google Scholar
• Bradby G VH, Hawkins C F, Hoare A M. Cimetidine (Tagamet) in oesophageal reflux. Clin Trial J 1980; 17: 81–3
   Google Scholar
• Greaney M G, Irvin T T. Cimetidine for the treatment of symptomatic gastro-oesophageal reflux. Br J Clin Pract 1981; 35: 21–4
   PubMedGoogle Scholar
• Smart H L, James P D, Atkinson M, Hawkey C J. Treatment of reflux oesophagitis with Trimoprostil. Digestion 1989; 44: 52–6
   PubMed Web of Science ®Google Scholar
• Berstad A. Overview of ranitidine in reflux-oesophagitis: its effect on symptoms, endoscopic appearance and histology. The clinical use of ranitidine, J J Misiezicw, K J Wormsley. Medicine Publishing Foundation, Oxford 1982; 297–304
   Google Scholar
• Grove O, Bekker C, Jeppe-Jansen M G, Karstoft E, Sauchez G, Axelsson C K, et al. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial. Scand J Gastroenterol 1985; 20: 457–61
   PubMed Web of Science ®Google Scholar
• Harvey R F, Gordon P C, Hadley N, et al. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 1987; 2: 1200–3
   PubMed Web of Science ®Google Scholar
• Robinson M G, Orr W C, McAllum R, Nardi R. Do endoscopic findings influence response to H2 antagonist therapy for gastroesophageal reflux disease?. Am J Gastroenterol 1987; 82: 519–22
   PubMed Web of Science ®Google Scholar
• Hine K R, Holmes G K, Melikian V, et al. Ranitidine in reflux esophagitis; a double-blind placebo-controlled study. Digestion 1984; 29: 119–23
   PubMed Web of Science ®Google Scholar
• Zeitoun P, Carteret E, Thiefin G, Renard P, Le Louargant M. Histoire naturelle des oesophagites par reflux. Med Hyg 1989; 47: 2641–3
   Google Scholar
• Rex J C, Andersen H A, Bartholomew L G, Cain J C. Esophageal hiatal hernia—a 10-year study of medically treated cases. JAMA 1961; 178: 117–20
   Web of Science ®Google Scholar
• Palmer E D. The hiatus hernia-esophagitis-esophageal stricture complex: twenty-year prospective study. Am J Med 1968; 44: 566–71
   PubMed Web of Science ®Google Scholar
• Brunnen P L, Karmody A M, Needham C D. Severe ptptic oesophagitis. Gut 1969; 10: 831–7
   PubMed Web of Science ®Google Scholar
• Lieberman D A, Keeffe E B. Treatment of severe reflux esophagitis with cimetidine and metroclopramide. Ann Intern Med 1986; 104: 21–6
   PubMed Web of Science ®Google Scholar
• Koelz H R. Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials. Scand J Gastroenterol 1989; 24(Suppl 156)25–36
   Google Scholar
• Tytgat G NJ, Nicolai J J, Reman F C. Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. A review of three large, double-blind, controlled trials. Gastroenterology 1990; 99: 629–34
   PubMed Web of Science ®Google Scholar
• Maxton D G, Heald J, Whorwell P J, Haboubi N Y. Controlled trial of pyrogastrone and cimetidine in the treatment of reflux oesophagitis. Gut 1990; 31: 351–4
   PubMed Web of Science ®Google Scholar
• Johansson K E, Boeryd B, Johansson K, Tibbling L. Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease. Scand J Gastroenterol 1986; 21: 769–78
   PubMed Web of Science ®Google Scholar
• Harvey R F, Hadley N, Gill T R, et al. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 1987; 2: 1200–3
   PubMed Web of Science ®Google Scholar
• Berenson M M, Sontag S, Robinson M G, McCallum R M, GERD study group. J Clin Gastroenterol 1987; 5: 499–503
   Google Scholar
• Hetzel D P, McCallum R W. The natural history of reflux esophagitis. Acta Endosc 1993; 23: 73–81
   Google Scholar
• Kuster E, Ros E, Toledo-Pimentel V, et al. Predictive factors of the long-term outcome in gastro-oesophageal reflux disease: six years follow up of 107 patients. Gut 1994; 35: 8–14
   PubMed Web of Science ®Google Scholar
• Poynard T, French Co-operative Study Group. Relapse rate of patients after healing of oesophagitis—a prospective study of alginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993; 7: 385–92
   PubMed Web of Science ®Google Scholar
• Schindlbeck N E, Klauser A G, Berghammer G, Londong W, Müller-Lissner S A. Three year follow up of patients with gastroesophageal reflux disease. Gut 1992; 33: 1016–9
   PubMed Web of Science ®Google Scholar